Cytokinetics Inc Strategic Asset Allocation Index
Cytokinetics Inc strategic asset allocation index. Cytokinetics Inc (CYTK) has a Strategic Asset Allocation Index of 281.3% as of June 2024. Strategic assets (PP&E of $- plus long-term investments of $305.36 Million) total $305.36 Million, measured against net assets of $108.55 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Cytokinetics Inc (CYTK) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cytokinetics Inc (2004–2021)
Strategic asset allocation index of Cytokinetics Inc from 2004 to 2021. This chart shows how Cytokinetics Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2004 to 2021. As of June 2024, the index stands at 281.3%, representing strategic assets of $305.36 Million against net assets of $108.55 Million USD.
Cytokinetics Inc Strategic Asset Allocation Index by Year (2004–2021)
Cytokinetics Inc strategic asset allocation index by year from 2004 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Cytokinetics Inc from 2004 to 2021, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CYTK company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 92.4% | $225.32 Million | $73.27 Million | $152.05 Million | $243.86 Million | ▲ +48.0 pp |
| 2020 | 44.4% | $50.30 Million | $13.35 Million | $36.95 Million | $113.38 Million | ▲ +32.0 pp |
| 2018 | 12.4% | $3.20 Million | $3.20 Million | $0.00 | $25.93 Million | ▼ -5.9 pp |
| 2017 | 18.3% | $20.09 Million | $3.57 Million | $16.52 Million | $109.84 Million | ▲ +6.3 pp |
| 2016 | 12.0% | $11.31 Million | $3.64 Million | $7.67 Million | $94.36 Million | ▲ +9.2 pp |
| 2015 | 2.8% | $1.93 Million | $1.75 Million | $179.00K | $68.59 Million | ▲ +1.0 pp |
| 2014 | 1.8% | $1.64 Million | $1.64 Million | $- | $92.06 Million | ▼ -5.1 pp |
| 2013 | 6.8% | $3.72 Million | $1.22 Million | $2.50 Million | $54.44 Million | ▲ +5.4 pp |
| 2012 | 1.4% | $997.00K | $997.00K | $- | $71.44 Million | ▼ -1.3 pp |
| 2011 | 2.7% | $1.31 Million | $1.31 Million | $- | $48.18 Million | ▼ -0.6 pp |
| 2010 | 3.3% | $2.32 Million | $2.32 Million | $- | $70.52 Million | ▼ -0.4 pp |
| 2009 | 3.7% | $3.71 Million | $3.71 Million | $- | $101.43 Million | ▼ -6.6 pp |
| 2008 | 10.2% | $5.09 Million | $5.09 Million | $- | $49.77 Million | ▲ +2.5 pp |
| 2007 | 7.7% | $7.73 Million | $7.73 Million | $- | $99.92 Million | ▼ -0.9 pp |
| 2006 | 8.7% | $9.20 Million | $9.20 Million | $- | $106.31 Million | ▲ +0.3 pp |
| 2005 | 8.4% | $6.18 Million | $6.18 Million | $- | $73.56 Million | ▲ +1.6 pp |
| 2004 | 6.8% | $7.34 Million | $7.34 Million | $- | $107.56 Million | — |